David R. Liu: Can we cure genetic diseases by rewriting DNA?
刘如谦: 我们能重写DNA来治疗基因疾病吗?
David R. Liu leads a research group that combines chemistry and evolutionary techniques to create revolutionary new medicines. Full bio
Double-click the English transcript below to play the video.
your mother and father ever gave you
of three billion letters of DNA
with three billion components,
made by your cells,
比如C(胞嘧啶),
or base, such as C,
G(鸟嘌呤)或者A(腺嘌呤)。
such as T, G or A.
will collectively accumulate
会累计发生数亿次
这也被称作“点突变”。
which are also called "point mutations."
point mutations are harmless.
an important capability in a cell
in harmful ways.
from your parents
in your development,
你的大部分甚至全部细胞
that many or all of your cells
of hundreds of millions of people
或者家族黑蒙性痴呆症。
or Tay-Sachs disease.
caused by point mutations
这些不幸的遗传疾病
哪个具体字母(碱基)发生了突变,
the exact single-letter change
因此理论上,我们可以治愈它。
and, in theory, could cure the disease.
a single A to T point mutations
are born with a T
某个位置有一个T,
that these wonderful, bright kids
by about age 14.
to efficiently correct point mutations
T back into a C.
最近成功发明了一种技术,
in developing such a capability,
as sources of infection,
prone to being infected,
来抵抗病毒感染。
to fight viral infection.
is now better known as CRISPR.
is this purple protein
是这种紫色的蛋白质,
可以剪断DNA链,
scissors to cut DNA,
between bacterial and viral DNA,
细菌和病毒的DNA,
defense system.
programmed to search for,
a virus for the first time,
of that virus's DNA
to direct the CRISPR scissors
就剪断病毒的DNA链。
during a future infection.
the function of the cut viral gene,
会扰乱该病毒基因的表达功能,
the virus's life cycle.
Emmanuelle Charpentier, George Church,
埃马纽埃尔·卡彭蒂耶、乔治·丘奇,
CRISPR的剪刀可以被编辑,
could be programmed
chosen by bacteria.
of the cut gene, typically,
of random mixtures of DNA letters
useful for some applications.
that cause genetic diseases,
点突变而言,
对病人而言并没有意义,
won't benefit patients,
needs to be restored,
already-mutated hemoglobin gene
to make healthy red blood cells.
new DNA sequences into cells
一些新的DNA片段到细胞中,
surrounding a cut site,
对大部分细胞不起作用,
in most types of cells,
still predominate.
I've dreamed of a future
我梦想着未来有一天,
or maybe even cure
to fix point mutations,
人类基因疾病的主因,
working with my students
应用于单个DNA碱基上的方法,
directly on an individual DNA base,
终止引起基因疾病的变异。
the mutations that cause genetic diseases.
are molecular machines
searching mechanism of CRISPR scissors,
类似CRISPR剪刀的可编程搜索机制,
one base to another base
CRISPR proteins as molecular scissors,
比作分子剪刀的话,
one DNA letter into another
the atoms of one DNA base
the first base editor, shown here,
第一个碱基编辑器,如图所示,
from the same organism.
and disabling the ability to cut DNA
剪断DNA的功能,
and bind a target DNA sequence
scissors, shown in blue,
图中蓝色的部分,
在这里用红色标出,
on the DNA base C,
that behaves like T.
to the first two proteins
用紫色标出的蛋白质
from being removed by the cell.
three-part protein
由3部分组成的蛋白质,
将基因组特定位置的
allows us to convert Cs into Ts
our work was only half done.
我们的工作也仅仅完成了一半。
必须形成碱基对。
have to form base pairs.
on one DNA strand creates a mismatch,
细胞需要决定替换哪一条链。
by deciding which strand to replace.
this three-part protein
这个由3部分组成的蛋白质,
as the one to be replaced
of what used to be a C-G base pair
in the lab, Alexis Komor,
this first class of base editor,
disease-associated point mutations,
与点突变有关的疾病中,
that this first base editor can reverse
14%或5000种左右。
or 5,000 or so pathogenic point mutations.
of disease-causing point mutations
a second class of base editor,
或T都转变为C的工具。
As into Gs or Ts into Cs.
a former post doc in the lab,
Nicole Gaudelli的领导下,
this second class of base editor,
纠正近一半的致病点基因突变,
almost half of pathogenic point mutations,
the rapid-aging disease progeria.
borrow, once again,
带到基因组的正确位置。
to the right site in a genome.
an incredible problem;
一个棘手的难题;
可以将A转化成G
A into G or T into C
look for another project,
of a naturally occurring protein
进化我们自己的蛋白质
our own protein in the laboratory
that behaves like G,
化学反应的蛋白质开始。
that performs related chemistry on RNA.
survival-of-the-fittest selection system
of protein variants
chemistry to survive.
这里用蓝色标示,
scissors, shown in blue,
strand-nicking strategy
the nonedited T with a C
到G-C碱基对的转变。
of an A-T base pair to a G-C base pair.
interrupted by applause.
first two classes of base editors
and one and a half years ago.
生物医学团队广泛使用。
by the biomedical research community.
more than 6,000 times
1000位研究者的请求
1,000 researchers around the globe.
have been published already,
从老鼠到灵长类动物的生物体中
ranging from bacteria
human clinical trials,
a critical milestone towards that goal
that cause human genetic diseases.
的一个科学家合作小组,
led by Luke Koblan and Jon Levy,
将第二代碱基编辑器
that second base editor
T back into a C
逆转了其导致的后果。
at the DNA, RNA and protein levels.
been used in animals
correcting a point mutation
就可以逆转病症。
single DNA letter changes
to probe the role of individual letters
来探索单个碱基
with diseases such as cancer.
Beam Therapeutics and Pairwise Plants,
Beam Therapeutics和Pairwise Plants,
to treat human genetic diseases
than the past three years:
its full potential
with genetic diseases.
are thought to be treatable
很小一部分细胞
of cells in an organ,
like base editors
to deliver base editors
that give you a cold
delivery strategies
new molecular machines
另一个碱基对,
to another base pair
不必要的编辑
at off-target locations in cells
doctors, ethicists and governments
伦理学家和政府合作,
碱基编辑用于深思熟虑、
that base editing is applied thoughtfully,
even just five years ago
molecular machines
an individual base pair
in the human genome
of other outcomes,
are you reading?"
group of students
使得我们可以改造自身,
what we could design ourselves
原本无法进化出的特征,
to evolve what we couldn't,
科幻小说般的渴望
that science-fiction-like aspiration
we give our children
three billion letters of DNA,
and repair them.
ABOUT THE SPEAKER
David R. Liu - Chemical biologistDavid R. Liu leads a research group that combines chemistry and evolutionary techniques to create revolutionary new medicines.
Why you should listen
During his PhD research at Berkeley, David R. Liu initiated the first general effort to expand the genetic code in living cells. As a professor at Harvard and the Broad Institute, Liu integrates chemistry and evolution to illuminate biology and develop next-generation therapeutics. He has published more than 170 papers and is an inventor on more than 65 issued US patents.
Liu's major research interests include development and use of genome editing technologies to study and treat genetic diseases; the evolution of proteins with novel therapeutic potential; and the discovery of bioactive synthetic molecules using DNA-encoded libraries. Base editing, phage-assisted continuous evolution (PACE) and DNA-encoded libraries are three technologies pioneered in his laboratory that are now widely used in the biomedical sciences. Liu has also cofounded six biotechnology and therapeutics companies, including Editas Medicine, Beam Therapeutics, Pairwise Plants and Exo Therapeutics.
Liu grew up in Riverside, California, where playing with insects in his backyard crystallized his interest in science. He also is passionate about photography and has been banned from playing blackjack at virtually every major casino in Las Vegas after developing a creative and highly advantageous card-counting system.
David R. Liu | Speaker | TED.com